JP2019517828A5 - - Google Patents

Download PDF

Info

Publication number
JP2019517828A5
JP2019517828A5 JP2019518374A JP2019518374A JP2019517828A5 JP 2019517828 A5 JP2019517828 A5 JP 2019517828A5 JP 2019518374 A JP2019518374 A JP 2019518374A JP 2019518374 A JP2019518374 A JP 2019518374A JP 2019517828 A5 JP2019517828 A5 JP 2019517828A5
Authority
JP
Japan
Prior art keywords
seq
composition
clostridium
purified
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019518374A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019517828A (ja
JP7168558B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/037498 external-priority patent/WO2017218680A1/en
Publication of JP2019517828A publication Critical patent/JP2019517828A/ja
Publication of JP2019517828A5 publication Critical patent/JP2019517828A5/ja
Priority to JP2022172637A priority Critical patent/JP7483828B2/ja
Application granted granted Critical
Publication of JP7168558B2 publication Critical patent/JP7168558B2/ja
Priority to JP2024074166A priority patent/JP2024109615A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019518374A 2016-06-14 2017-06-14 Ｃｌｏｓｔｒｉｄｉｕｍ ｄｉｆｆｉｃｉｌｅ感染症の処置 Active JP7168558B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022172637A JP7483828B2 (ja) 2016-06-14 2022-10-27 Ｃｌｏｓｔｒｉｄｉｕｍ ｄｉｆｆｉｃｉｌｅ感染症の処置
JP2024074166A JP2024109615A (ja) 2016-06-14 2024-05-01 Ｃｌｏｓｔｒｉｄｉｕｍ ｄｉｆｆｉｃｉｌｅ感染症の処置

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662349914P 2016-06-14 2016-06-14
US62/349,914 2016-06-14
PCT/US2017/037498 WO2017218680A1 (en) 2016-06-14 2017-06-14 Treatment of clostridium difficile infection

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022172637A Division JP7483828B2 (ja) 2016-06-14 2022-10-27 Ｃｌｏｓｔｒｉｄｉｕｍ ｄｉｆｆｉｃｉｌｅ感染症の処置

Publications (3)

Publication Number Publication Date
JP2019517828A JP2019517828A (ja) 2019-06-27
JP2019517828A5 true JP2019517828A5 (enExample) 2020-07-27
JP7168558B2 JP7168558B2 (ja) 2022-11-09

Family

ID=60664224

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019518374A Active JP7168558B2 (ja) 2016-06-14 2017-06-14 Ｃｌｏｓｔｒｉｄｉｕｍ ｄｉｆｆｉｃｉｌｅ感染症の処置
JP2022172637A Active JP7483828B2 (ja) 2016-06-14 2022-10-27 Ｃｌｏｓｔｒｉｄｉｕｍ ｄｉｆｆｉｃｉｌｅ感染症の処置
JP2024074166A Pending JP2024109615A (ja) 2016-06-14 2024-05-01 Ｃｌｏｓｔｒｉｄｉｕｍ ｄｉｆｆｉｃｉｌｅ感染症の処置

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022172637A Active JP7483828B2 (ja) 2016-06-14 2022-10-27 Ｃｌｏｓｔｒｉｄｉｕｍ ｄｉｆｆｉｃｉｌｅ感染症の処置
JP2024074166A Pending JP2024109615A (ja) 2016-06-14 2024-05-01 Ｃｌｏｓｔｒｉｄｉｕｍ ｄｉｆｆｉｃｉｌｅ感染症の処置

Country Status (13)

Country Link
US (8) US9999641B2 (enExample)
EP (2) EP4282489A3 (enExample)
JP (3) JP7168558B2 (enExample)
KR (4) KR102658297B1 (enExample)
CN (1) CN109562133A (enExample)
AU (2) AU2017285211B2 (enExample)
CA (2) CA3226196A1 (enExample)
DK (1) DK3468573T5 (enExample)
ES (1) ES2960053T3 (enExample)
FI (1) FI3468573T3 (enExample)
MX (2) MX2018015522A (enExample)
PT (1) PT3468573T (enExample)
WO (1) WO2017218680A1 (enExample)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
CA2892588A1 (en) 2011-12-01 2013-06-06 School Corporation, Azabu Veterinary Medicine Educational Institution Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
KR102658297B1 (ko) 2016-06-14 2024-04-18 베단타 바이오사이언시즈, 인크. 클로스트리디움 디피실레 감염의 치료
CA3211208A1 (en) 2017-04-03 2018-10-11 Gusto Global, Llc Rational design of microbial-based biotherapeutics
CN116732106A (zh) 2017-04-20 2023-09-12 E开创生物技术股份有限公司 产生基因修改的动物的方法
JP2020523326A (ja) 2017-06-14 2020-08-06 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物
JP2021501185A (ja) 2017-10-30 2021-01-14 セレス セラピューティクス インコーポレイテッド 抗生物質耐性を処置するための組成物及び方法
AU2018365071B2 (en) * 2017-11-09 2025-09-11 Vedanta Biosciences, Inc. Compositions and methods for the treatment of allergy
EP4410954A3 (en) 2017-12-11 2025-01-15 Vedanta Biosciences, Inc. Compositions and methods for suppressing pathogenic organisms
CN111712260A (zh) * 2018-01-31 2020-09-25 伊夫罗生物科学公司 使用毛螺菌科细菌治疗免疫病症的组合物和方法
WO2019169143A1 (en) * 2018-02-28 2019-09-06 Evelo Biosciences, Inc. Compositions and methods for treating cancer using turicibacter sanguinis
JP2021519763A (ja) * 2018-03-29 2021-08-12 セレス セラピューティクス インコーポレイテッド 炎症性腸疾患を治療するための組成物及び方法
WO2019200271A1 (en) 2018-04-13 2019-10-17 White Dog Labs, Inc. An improved method for selecting probiotics
CN110468061B (zh) * 2018-05-11 2024-03-08 韩国亿诺生物有限公司 具有预防或治疗癌症的效果的新型菌株
LT3743086T (lt) * 2018-05-11 2022-06-10 4D Pharma Research Limited Kompozicijos, apimančios bakterinius kamienus
JP2021527639A (ja) * 2018-06-19 2021-10-14 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 生物療法製品を含む剤形
JP7558170B2 (ja) * 2018-08-17 2024-09-30 ヴェダンタ バイオサイエンシーズ インコーポレーテッド 腸内毒素症を減少させ、微生物叢を復元する方法
EP3890505A4 (en) * 2018-12-05 2022-11-02 Seres Therapeutics, Inc. COMPOSITIONS FOR STABILIZING BACTERIA AND THEIR USES
EP3893906A1 (en) * 2018-12-12 2021-10-20 4D Pharma Research Limited Compositions comprising bacterial strains
WO2020120714A1 (en) * 2018-12-12 2020-06-18 4D Pharma Research Limited Compositions comprising bacterial strains
IL265735A (en) 2019-03-31 2019-05-30 Biomica A microbial consortium and its uses
WO2021011887A1 (en) * 2019-07-17 2021-01-21 University Of Utah Research Foundation Clostridia consortia compositions and methods of treating obesity, metabolic syndrome and irritable bowel disease
WO2021030198A1 (en) * 2019-08-09 2021-02-18 Vedanta Biosciences, Inc. Compositions and methods for suppressing pathogenic organisms
GB201911728D0 (en) * 2019-08-15 2019-10-02 Genome Res Ltd Bacterial composistions for the treatment of disease
US11806342B2 (en) * 2019-10-07 2023-11-07 Purdue Research Foundation Diiodohydroxyquinoline for the treatment of clostridium difficile infection
KR102485269B1 (ko) * 2019-10-18 2023-01-06 주식회사 지놈앤컴퍼니 비피도박테리움 비피덤을 포함하는 면역력 증강 또는 개선용 조성물
WO2021098991A1 (en) 2019-11-20 2021-05-27 4D Pharma Research Limited Compositions comprising bacterial strains
EP3858363A1 (en) 2020-01-28 2021-08-04 Institut national de recherche pour l'agriculture, l'alimentation et l'environnement Composition for treating intestinal or pulmonary diseases
AU2021217391B2 (en) * 2020-02-07 2026-03-26 International N&H Denmark Aps Feed compositions for animal health
GB202007452D0 (en) * 2020-05-19 2020-07-01 Microbiotica Ltd Threrapeutic bacterial composition
EP4189063A4 (en) * 2020-07-28 2024-08-07 Icahn School of Medicine at Mount Sinai COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL TRACT INFECTIONS
CA3188645A1 (en) * 2020-08-14 2022-02-17 Prolacta Bioscience, Inc. Human milk oligosaccharide compositions for use with bacteriotherapies
WO2022039561A1 (ko) * 2020-08-21 2022-02-24 서울대학교산학협력단 클로스트리디움 디피실리 감염의 치료 또는 예방용 조성물
US20230381247A1 (en) * 2020-10-21 2023-11-30 Gusto Global, Llc Microbial-based compositions for systemic inflammation control
IL302830A (en) 2020-11-13 2023-07-01 Egenesis Inc Cells, tissues, organs and animals with one or more genes that have been modified for improved survival and tolerance of a different-sex transplant
AU2021388169A1 (en) * 2020-11-25 2023-07-13 Seres Therapeutics, Inc. Designed bacterial compositions for treating graft-versus-host-disease
KR102296288B1 (ko) * 2020-12-31 2021-09-01 주식회사 바이오뱅크힐링 락토바실러스 루테리 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
KR102269966B1 (ko) * 2021-01-12 2021-06-28 주식회사 바이오뱅크힐링 루미노코쿠스 파에시스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
WO2022159711A1 (en) 2021-01-21 2022-07-28 Vedanta Biosciences, Inc. Compositions and methods for treating hepatic encephalopathy
EP4294413A1 (en) * 2021-02-18 2023-12-27 Vedanta Biosciences, Inc. Compositions and methods for suppressing pathogenic organisms
EP4341382A4 (en) * 2021-05-10 2025-04-30 Microba Ip Pty Ltd COMPOSITIONS AND METHODS FOR TREATING DISEASES
KR102331485B1 (ko) * 2021-08-02 2021-12-01 주식회사 바이오뱅크힐링 블라우티아 웩슬러래 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
KR102331483B1 (ko) * 2021-08-02 2021-12-01 주식회사 바이오뱅크힐링 류코노스톡 락티스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
KR102351147B1 (ko) * 2021-08-02 2022-01-14 주식회사 바이오뱅크힐링 블라우티아 오베움 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
KR102351146B1 (ko) * 2021-08-02 2022-01-14 주식회사 바이오뱅크힐링 페디오코쿠스 에시디락티시 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
WO2023014048A1 (ko) * 2021-08-02 2023-02-09 주식회사 바이오뱅크힐링 비피도박테리움 속 균주 또는 페디오코쿠스 속 균주 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
US20240335481A1 (en) * 2021-08-02 2024-10-10 Biobankhealing Inc Blautia sp. strain, leuconostoc sp. strain, or ruminococcus sp. strain and endoplasmic reticulum derived therefrom, and anti-inflammatory and antibacterial uses thereof
KR102331486B1 (ko) * 2021-08-02 2021-12-01 주식회사 바이오뱅크힐링 비피도박테리움 슈도카테눌라튬 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
KR102351145B1 (ko) * 2021-08-02 2022-01-14 주식회사 바이오뱅크힐링 비피도박테리움 롱검 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
KR102331484B1 (ko) * 2021-08-02 2021-12-01 주식회사 바이오뱅크힐링 블라우티아 마실리엔시스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
KR102351148B1 (ko) * 2021-08-02 2022-01-14 주식회사 바이오뱅크힐링 페디오코쿠스 펜토사세우스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
KR102792000B1 (ko) * 2021-10-21 2025-04-08 경북대학교 산학협력단 신규한 락토바실러스 루테리 psc102 균주 및 이의 용도
WO2023075458A1 (ko) * 2021-10-27 2023-05-04 주식회사 바이오뱅크힐링 신규 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
KR102337998B1 (ko) * 2021-11-03 2021-12-14 주식회사 바이오뱅크힐링 로제부리아 파에시스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
KR102337995B1 (ko) * 2021-11-10 2021-12-14 주식회사 바이오뱅크힐링 아가토바쿨룸 부티리시프로두켄스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
WO2023132628A1 (ko) * 2022-01-04 2023-07-13 주식회사 바이오뱅크힐링 신규 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
KR102365420B1 (ko) * 2022-01-04 2022-02-23 주식회사 바이오뱅크힐링 로제부리아 인테스티날리스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
KR102444328B1 (ko) * 2022-03-11 2022-09-19 주식회사 바이오뱅크힐링 아나에로스티페스 하드루스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
US20260165955A1 (en) 2022-03-18 2026-06-18 Meiji Co., Ltd. Composition for controlling growth of bacteria of the genus collinsella and use thereof
KR102626400B1 (ko) * 2022-08-31 2024-01-19 주식회사 바이오뱅크힐링 도레아 론기카테나 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
WO2024211569A1 (en) * 2023-04-04 2024-10-10 Vedanta Biosciences, Inc. Compositions and methods for treating or preventing clostridium difficile infection, neutropenia, cardiovascular disease, asthma, and/or cancer
KR102628942B1 (ko) * 2023-08-08 2024-01-26 주식회사 바이오뱅크힐링 레비락토바실러스 브레비스 균주, 및 그의 유래의 소포체및 그의 항염증 및 항균 용도
WO2025033635A1 (ko) * 2023-08-08 2025-02-13 주식회사 바이오뱅크힐링 신규 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
KR102620185B1 (ko) * 2023-08-08 2024-01-04 주식회사 바이오뱅크힐링 블라우티아 호미니스 균주, 및 그의 유래의 소포체및 그의 항염증 및 항균 용도
WO2025033636A1 (ko) * 2023-08-08 2025-02-13 주식회사 바이오뱅크힐링 신규 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
KR102620186B1 (ko) * 2023-08-08 2024-01-04 주식회사 바이오뱅크힐링 리모실락토바실러스 뮤코세 균주, 및 그의 유래의 소포체및 그의 항염증 및 항균 용도
WO2025076184A1 (en) 2023-10-03 2025-04-10 Vedanta Biosciences, Inc. Methods of decreasing dysbiosis and restoring a microbiome
WO2025093777A1 (en) 2023-11-05 2025-05-08 Human Biome Institute S.A. Functional compositions and methods of use thereof in the treatment and recurrence prophylaxis of clostridioides difficile infection and restoration of healthy microbiota
WO2025116014A1 (ja) 2023-12-01 2025-06-05 株式会社明治 Ｓｕｂｄｏｌｉｇｒａｎｕｌｕｍ属細菌増殖制御用組成物
CN117797176B (zh) * 2024-03-01 2024-07-02 南京大学 双孢梭菌在制备治疗非酒精性脂肪性肝病药物中的应用和一种药物

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4205A (en) 1845-09-23 Spark-arrester
US132A (en) 1837-02-25 Improvement in propelling machinery by magnetism and electro-magnetism
US3261761A (en) 1962-05-07 1966-07-19 Arthur W Anderson Method of freeze drying bacterial cultures
EP0952773B1 (en) 1995-09-15 2005-11-23 Dale N. Gerding Methods and compositions for prevention and treatment of clostridium difficile-associated diseases
US6368586B1 (en) 1996-01-26 2002-04-09 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
AUPQ899700A0 (en) * 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
EP1815016B1 (en) 2004-11-01 2012-06-27 George Mason University Compositions and methods for diagnosing colon disorders
CN101171019B (zh) 2005-03-03 2012-05-23 株式会社明治 免疫功能调节剂
WO2010036876A2 (en) 2008-09-25 2010-04-01 New York University Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
GB0916335D0 (en) 2009-09-17 2009-10-28 Martin W J Medicaments
EP4663746A3 (en) 2010-02-01 2026-04-15 Ferring Microbiome Inc. Bacteriotherapy for clostridium difficile colitis
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
CA2807242C (en) * 2010-08-04 2017-05-02 Thomas Julius Borody Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
WO2012024638A2 (en) 2010-08-20 2012-02-23 New York University Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
WO2012098358A1 (en) 2011-01-20 2012-07-26 Biopharma Technology Ltd Freeze drying method
CA2837081C (en) 2011-05-23 2019-06-25 Washington State University Research Foundation Use of photosynthetic pigment stabilizing agents to regulate ripening and quality in fruits and vegetables
EP2756071B1 (en) 2011-09-14 2017-12-20 University Of Guelph Media supplements and methods to culture human gastrointestinal anaerobic microorganisms
CA2892588A1 (en) * 2011-12-01 2013-06-06 School Corporation, Azabu Veterinary Medicine Educational Institution Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
IN2014DN07752A (enExample) 2012-02-29 2015-05-15 Ethicon Endo Surgery Inc
JP6201982B2 (ja) 2012-03-30 2017-09-27 味の素株式会社 糖尿病誘起細菌
US10130665B2 (en) 2012-05-18 2018-11-20 Genome Research Limited Method for identifying bacteria for bacteriotherapy
CN102743420A (zh) 2012-06-06 2012-10-24 上海交通大学 改善肠道菌群结构的方法及应用
WO2014029578A1 (en) 2012-08-24 2014-02-27 Haldor Topsøe A/S Method and catalyzed filter element with improved alkali-resistance for flue gas cleaning
MX2015006491A (es) 2012-11-23 2015-12-03 Seres Health Inc Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas.
MX369877B (es) * 2013-02-04 2019-11-25 Seres Therapeutics Inc Composiciones y metodos.
US9907755B2 (en) 2013-03-14 2018-03-06 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
US20160040215A1 (en) 2013-03-14 2016-02-11 Seres Therapeutics, Inc. Methods for Pathogen Detection and Enrichment from Materials and Compositions
JP2016519664A (ja) 2013-03-15 2016-07-07 セレス セラピューティクス インコーポレイテッド ネットワークを基にした微生物組成物及び方法
US9669059B2 (en) 2013-03-15 2017-06-06 University Of Florida Research Foundation, Incorporated Butyrogenic bacteria as probiotics to treat clostridium difficile
US9764019B2 (en) 2013-07-09 2017-09-19 Vedanta Biosciences, Inc. Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
AU2014331610B2 (en) 2013-10-03 2019-11-07 Trustees Of The University Of Pennsylvania Compositions comprising a defined microbiome and methods of use thereof
MX367109B (es) 2013-11-25 2019-08-05 Seres Therapeutics Inc Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
WO2015156419A1 (en) 2014-04-10 2015-10-15 Riken Compositions and methods for induction of th17 cells
EP3134509B1 (en) 2014-04-23 2026-01-21 Cornell University Modulation of fat storage in a subject by altering population levels of christensenellaceae in the gi tract
EP3146065B1 (en) 2014-05-19 2024-11-13 Memorial Sloan Kettering Cancer Center Methods and compositions for reducing clostridium difficile infection
EP4529950A3 (en) 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
ES3010296T3 (en) 2014-11-25 2025-04-02 Memorial Sloan Kettering Cancer Center Intestinal microbiota and gvhd
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
CN114159476A (zh) 2015-05-14 2022-03-11 克雷斯顿沃控股公司 用于粪便菌群移植的组合物以及用于制备和使用它们的方法和用于递送它们的装置
EP3297727A1 (en) 2015-05-21 2018-03-28 Yeda Research and Development Co. Ltd Bacterial populations for promoting health
US20180153944A1 (en) 2015-06-09 2018-06-07 Regents Of The University Of Minnesota Methods for detecting risk of having a bloodstream infection and compositions for reducing the risk
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PE20180243A1 (es) 2015-06-15 2018-01-31 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
EP3662917A1 (en) 2015-06-15 2020-06-10 4D Pharma Research Limited Compositions comprising bacterial strains
LT3360559T (lt) 2015-06-15 2019-12-27 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
EA201890097A1 (ru) 2015-06-22 2018-07-31 Президент Энд Феллоуз Оф Гарвард Колледж Индукция регуляторных т-клеток lamina propria
US20180200308A1 (en) 2015-07-08 2018-07-19 Seres Therapeutics, Inc. Methods of treating colitis
WO2017035188A1 (en) 2015-08-24 2017-03-02 Nubyiota Llc Systems and methods for treating a dysbiosis using fecal-derived bacterial populations
EP3368050A1 (en) 2015-10-26 2018-09-05 Crestovo Holdings LLC Compositions and methods for fecal microbiota-related therapy
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41013A (fr) 2015-11-20 2017-08-30 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
US20190247447A1 (en) 2015-11-24 2019-08-15 Seres Therapeutics, Inc. Designed bacterial compositions
MX373290B (es) 2016-03-04 2020-06-18 4D Pharma Plc Composiciones que comprenden cepas bacterianas.
US20170290889A1 (en) 2016-04-11 2017-10-12 New York University Methods and compositions for treating dysbiosis and gastrointestinal and inflammatory disorders
KR102658297B1 (ko) 2016-06-14 2024-04-18 베단타 바이오사이언시즈, 인크. 클로스트리디움 디피실레 감염의 치료
WO2018005606A1 (en) 2016-06-28 2018-01-04 Synthetic Biologics, Inc. Microbiome protection from oral antibiotics
WO2018080477A1 (en) 2016-10-26 2018-05-03 The Joan & Irwin Jacobs Technion-Cornell Institute Systems and methods for ultra-fast identification and abundance estimates of microorganisms using a kmer-depth based approach and privacy-preserving protocols
KR20210024481A (ko) 2018-05-24 2021-03-05 세레스 테라퓨틱스, 인코포레이티드 설계된 박테리아 조성물 및 이의 용도
JP7558170B2 (ja) 2018-08-17 2024-09-30 ヴェダンタ バイオサイエンシーズ インコーポレーテッド 腸内毒素症を減少させ、微生物叢を復元する方法
WO2022159711A1 (en) 2021-01-21 2022-07-28 Vedanta Biosciences, Inc. Compositions and methods for treating hepatic encephalopathy

Similar Documents

Publication Publication Date Title
JP2019048857A5 (enExample)
JP2018199695A5 (enExample)
FI3468573T3 (fi) Clostridium difficile -infektion hoito
RU2020132171A (ru) Новая бифидобактерия, характеризующаяся различными функциями, и ее применение
HRP20191344T1 (hr) Sastavi koji sadrže bakterijske sojeve
SI3209310T1 (en) Compositions containing bacterial strains
JP2019001815A5 (enExample)
JP2019108378A5 (enExample)
RU2018118651A (ru) Композиции и способы терапии, связанной с фекальной микробиотой
HRP20191096T1 (hr) Sastavi koje sadrže bakterijske blautia sojeve za liječenje visceralne hipersenzitivnosti
HRP20220578T1 (hr) Pripravci koji sadrže bakterijske sojeve
RU2008121602A (ru) Применение рв6 bacillus для профилактики или лечения желудочно- кишечных и иммунных заболеваний
FI3223835T3 (fi) Suolen mikrobisto ja gvhd
JP2016539119A5 (enExample)
JP2015517488A5 (enExample)
JP2012524548A5 (enExample)
JP2021518414A5 (enExample)
HRP20210780T1 (hr) Pripravci koji sadrže bakterijske sojeve
NZ713423A (en) Bacteriophage therapy
JP2015525566A5 (enExample)
JP2021502391A5 (enExample)
JP2021509916A5 (enExample)
CN105722852A (zh) 用于治疗口腔粘膜炎的新型肽和类似物
RU2019130941A (ru) РЕКОМБИНАНТНАЯ BCG, СВЕРХЭКСПРЕССИРУЮЩАЯ PhoP-PhoR
JP2014113137A5 (enExample)